Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
AMANTA

Amanta Healthcare Share Price

 

 

Amanta Healthcare live price: ₹131.61. It opened at ₹134 vs previous close ₹133; intraday high/low: ₹137/₹130. The 50 DMA stands at ₹120.64.

Amanta Healthcare Performance

  • Today's Low
  • ₹130
  • Today's High
  • ₹137
  • 52 Week Low
  • ₹92
  • 52 Week High
  • ₹154
  • Open Price₹134
  • Previous Close₹133
  • Volume31,787
  • 50 DMA₹120.64
  • 100 DMA₹117.31
  • 200 DMA-

Amanta Healthcare Chart

Investment Returns

  • Over 1 Month + 16.77%
  • Over 3 Month + 26%
  • Over 6 Month + 11.51%
  • Over 1 Year + 5.02%

Smart Investing Starts Here Start SIP with Amanta Healthcare for Steady Growth!

Invest Now

Amanta Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 33.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 511
  • P/B Ratio
  • 2.4
  • Average True Range
  • 6.66
  • EPS
  • 4.11
  • Dividend Yield
  • 0
  • MACD Signal
  • 7.14
  • RSI
  • 57.13
  • MFI
  • 64.6

Amanta Healthcare Financials

Amanta Healthcare Technicals

EMA & SMA

Current Price
₹131.61
-0.93 (-0.7%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 8
  • 20 Day
  • ₹130.63
  • 50 Day
  • ₹120.64
  • 100 Day
  • ₹117.31
  • 200 Day
  • -

Resistance and Support

134.12 Pivot Speed
  • R3 142.04
  • R2 139.93
  • R1 136.23
  • S1 130.42
  • S2 128.31
  • S3 124.61

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Amanta Healthcare is a midsize pharmaceutical company manufacturing sterile dosage forms, including IV fluids, irrigation solutions, ophthalmic and respiratory formulations, and small-volume injectables. With versatile facilities, it partners with leading pharma firms as a reliable contract manufacturer for global healthcare needs.

Amanta Healthcare Ltd has an operating revenue of Rs. 282.74 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of 5% is okay, ROE of 10% is good. The company has a high debt to equity of 126%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 18% and 16% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 34 which is a POOR score indicating inconsistency in earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 62 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Amanta Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-19 Audited Results
2026-02-10 Quarterly Results
2025-11-11 Quarterly Results
2025-09-26 Quarterly Results

Amanta Healthcare Shareholding Pattern

63.72%
5.09%
0.05%
0.85%
0%
16%
14.29%

Amanta Healthcare FAQs

Amanta Healthcare share price is ₹131 As on 14 May, 2026 | 11:24

The Market Cap of Amanta Healthcare is ₹511 Cr As on 14 May, 2026 | 11:24

The P/E ratio of Amanta Healthcare is 33.4 As on 14 May, 2026 | 11:24

The PB ratio of Amanta Healthcare is 2.4 As on 14 May, 2026 | 11:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23